Laurel Wealth Planning’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-261
Closed -$144K 187
2022
Q4
$144K Hold
261
0.09% 68
2022
Q3
$132K Sell
261
-284
-52% -$159K 0.1% 68
2022
Q2
$296K Hold
545
0.21% 51
2022
Q1
$322K Hold
545
0.22% 56
2021
Q4
$364K Hold
545
0.28% 51
2021
Q3
$311K Hold
545
0.25% 50
2021
Q2
$275K Hold
545
0.24% 42
2021
Q1
$249K Hold
545
0.23% 41
2020
Q4
$254K Buy
+545
New +$256K 0.25% 38

Other funds holding TMO

Laurel Wealth Planning's TMO Position: Q1 2023 in Review

Laurel Wealth Planning sold out of Thermo Fisher Scientific (TMO) in Q1 2023, closing a stake of 261 shares — an estimated $144K sold.

Laurel Wealth Planning first reported a position in TMO in Q4 2020 and held it in 9 quarters. The position peaked at $364K in Q4 2021. 2,387 funds tracked by Wall St. Rank hold TMO as of Q1 2023.

  • Laurel Wealth Planning reported no remaining Thermo Fisher Scientific position as of Q1 2023 after selling out during the quarter.
  • Laurel Wealth Planning sold 261 Thermo Fisher Scientific shares in Q1 2023, an estimated $144K.
  • Laurel Wealth Planning first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 9 quarters.
  • Laurel Wealth Planning's Thermo Fisher Scientific position peaked at $364K in Q4 2021.
  • 2,387 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2023.

Based on Laurel Wealth Planning's 13F filing for Q1 2023, filed 18 Apr 2023.